Skip to content

Smoking Topography Study 2016

Smoking Topography Study 2016 - STS 2016

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42805
Enrollment
5
Registered
2015-12-30
Start date
2016-02-15
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gedrag Not applicable

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: A subject must meet all of the following criteria: - Male - 25-34 years old (birth year 1981 * 1990) - Caucasian - At least 3 years smoking Marlboro as usual brand - Used to smoke between 13 and 25 cigarettes a day (around a package/day)

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation: - Heavy smoker (minimum of 25 cigarettes/day) - Smokes more than one brand on a regular base. - Amount of cigarettes per day varies ±10, between days - Daily medication use - Experienced adverse effects due to smoking - Suffering chronic illness

Design outcomes

Primary

MeasureTime frame
Monitoring *habitual* smoking behavior, regarding the moments during the day the cigarettes are smoked, and how they are smoked (smoking topography) differing per cigarette. Output: a table with smoked cigarettes per participant with the associated nicotine and CO(Hb) measurement, and the smoking topography of each cigarette (puff volume, puff duration, puff interval, puff flow).

Secondary

MeasureTime frame
Nicotine, cotinine, COHb and leukocyte differentiation in blood per time points per participant. COHb measured with the finger sensor. Nicotine, cotinine, kreatinine and ureum in urine per time points per participant. Smoking-related DNA adducts in saliva per time points per participant. VOCs (1,3butadiene and benzene) and aldehydes (formaldehyde, acetaldehyde, acrolein) in breath per time points per participant. Metabolic state parameters (ASAT, ALAT, bilirubin, sodium, potassium, urea, TSH, CRP) only measured in baseline samples per participant.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)